Actionnariat et activité des initiés pour Precigen, Inc. (PGEN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $7.43 |
| Capitalisation | $2.7B |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $62.6M | $68.1M | $102.8M | $65.8M | $51.8M | $36.4M | $4.9M | $7.6M | $29.5M | $30.2M |
| Placements à Court Terme | $174.6M | $11.6M | $120.1M | $9.3M | $48.3M | $72.2M | $51.1M | $55.3M | $68.4M | $67.6M |
| Créances | $42.5M | $39.8M | $26.6M | $26.2M | $20.4M | $2.0M | $13.8M | $1.6M | $1.2M | $4.4M |
| Stocks | $21.1M | $20.5M | $21.4M | $16.1M | $11.4M | $326000 | $287000 | 0 | 0 | $9.6M |
| Actifs Courants | $315.2M | $154.0M | $285.5M | $234.6M | $148.9M | $156.6M | $118.2M | $68.8M | $102.4M | $115.2M |
| Immobilisations Corporelles | $64.7M | $112.7M | $128.9M | $86.2M | $44.3M | $18.6M | $15.3M | $14.1M | $18.8M | $18.4M |
| Goodwill | $157.2M | $153.3M | $149.6M | $63.8M | $54.4M | $37.6M | $36.9M | $26.6M | $19.1M | $15.2M |
| Actifs Incorporels | $225.6M | $232.9M | $129.3M | $68.3M | $65.4M | $52.3M | $44.5M | $40.7M | $4.5M | $3.2M |
| Actifs Totaux | $949.1M | $846.9M | $716.2M | $455.8M | $314.6M | $359.9M | $216.0M | $151.0M | $145.3M | $156.6M |
| Dettes Fournisseurs | $8.5M | $8.7M | $12.0M | $5.5M | $4.6M | $3.1M | $4.1M | $1.7M | $3.5M | $12.0M |
| Dette à Court Terme | $1.2M | $735000 | $945000 | $33.6M | $360000 | $52000 | $43.2M | 0 | 0 | 0 |
| Passifs Courants | $94.6M | $80.2M | $61.6M | $122.9M | $42.1M | $34.6M | $78.6M | $23.0M | $21.5M | $37.3M |
| Dette à Long Terme | $7.6M | $7.5M | $211.2M | $186.3M | $171.5M | $179.9M | 0 | 0 | 0 | $93.2M |
| Passifs Totaux | $379.8M | $300.3M | $337.5M | $384.1M | $247.4M | $252.5M | $89.7M | $32.5M | $106.8M | $135.7M |
| Réserves | -$729.3M | -$847.8M | -$1.33B | -$1.65B | -$1.82B | -$1.92B | -$1.87B | -$1.96B | -$2.09B | -$2.34B |
| Capitaux Propres | $560.2M | $533.6M | $362.9M | $71.7M | $67.2M | $107.3M | $126.3M | $118.5M | $38.5M | $20.9M |
| Dette Totale | $8.8M | $8.3M | $212.3M | $232.7M | $182.3M | $190.1M | $51.4M | $7.1M | $5.5M | $98.3M |
| Dette Nette | -$228.4M | -$71.4M | -$10.6M | $157.6M | $82.2M | $81.4M | -$4.5M | -$55.8M | -$92.4M | $432000 |
| Fonds de Roulement | $220.6M | $73.9M | $223.9M | $111.7M | $106.8M | $122.0M | $39.5M | $45.8M | $80.9M | $77.9M |
Entreprises liées: AMLX · DNTH · ELVN · IMTX · NKTR · ORIC · RLAY
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PGEN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions